Common challenges and workflow considerations
Achieving consistent, high-efficiency gene delivery in human iPSC-derived cells requires careful planning and handling. Transfecting post-mitotic cells, such as neurons with conventional plasmid DNA-based methods is notoriously challenging, because the cells do not divide and the nuclear envelope therefore remains intact, making plasmid DNA entry into the nucleus highly inefficient. This section outlines the most frequent challenges encountered during transfection workflows, alongside key considerations to help scientists optimise their next experiments.
Common challenges and workflow considerations
Achieving consistent, high-efficiency gene delivery in human iPSC-derived cells requires careful planning and handling. Transfecting post-mitotic cells, such as neurons with conventional plasmid DNA-based methods is notoriously challenging, because the cells do not divide and the nuclear envelope therefore remains intact, making plasmid DNA entry into the nucleus highly inefficient. This section outlines the most frequent challenges encountered during transfection workflows, alongside key considerations to help scientists optimise their next experiments.
Featured workshop: top tips for transfection in human iPSC-derived cells
Achieving high-quality, reproducible transfection data requires a thorough understanding of the workflow before beginning.
In this technical workshop, Tulin Tatar Ozkan, PhD and Sarah Hussain, BSc, scientists at 糖心原创 share practical advice for successfully transfecting hiPSC-derived cells. The session covers recommended reagents, cell-handling tips, and troubleshooting guidance to help avoid low efficiency or signs of cytotoxicity.
Understanding the different gene delivery methods before getting started
Before performing the cell mRNA transfection protocol or viral delivery, it is important to evaluate the available technologies and how they align with the specific cell type and experimental goals.
Evaluating transfection methods
- Biological (transduction): Viral vectors, such as lentivirus or adeno-associated virus (AAV), offer high efficiency and strong, stable expression, but can carry moderate-to-high toxicity and higher costs.
- Physical: Techniques like electroporation or nucleofection offer medium efficiency with moderate transient expression, but often result in moderate-to-high toxicity for the cells.
- Chemical (lipid-based): Lipid-based transfection provides medium-to-high efficiency and high transient expression with low-to-moderate toxicity, while remaining highly cost-effective and easy to perform.
- Chemical (calcium phosphates/cationic polymers): While very low cost and easy to use, these methods generally yield low efficiency and modest transient expression levels.
Choosing the best cargo: DNA vs. RNA
Transfecting post-mitotic cells can be challenging, and it benefits from tailored, optimised protocols.
- DNA-based delivery: In non-dividing cells, DNA-based delivery often yields low expression because plasmid DNA entry into the nucleus mainly relies on active nuclear import, thereby limiting its nuclear delivery.
- RNA-based delivery: Implementing an mRNA transfection protocol is more efficient for post-mitotic cells because nuclear entry is not required; the mRNA is delivered directly into the cytoplasm for immediate protein translation.
Step-by-step protocols for mRNA transfection and lentiviral transduction
Gene delivery in human iPSC-derived cells should follow a tailored workflow to guarantee high cell viability and optimal protein expression.
Step 1 | Thaw and culture cells: Optimise seeding density to ensure suitable confluency at the time of transfection and/or transduction. For example, plating ioGlutamatergic Neurons at 30,000 cells/cm虏 is highly recommended for lentiviral transduction protocol, while mRNA transfection protocol may benefit from slightly higher densities depending on the well format. Accurate cell counting prior to plating is crucial.
Step 2 | Prepare delivery reagents: For a lipid-based transfection protocol, premix the transfection complex consistently to avoid heterogeneity. Ensure a constant mRNA-to-reagent ratio is maintained if scaling by surface area for different plate formats. For lentiviral transduction, ensure viruses are properly thawed on ice and carefully calculate the desired Multiplicity of Infection (MOI) prior to application.
Step 3 | Deliver genetic material: Optimising delivery timing and duration are important steps to ensure high delivery efficiencies. Optimal conditions may vary across specific cell types and delivery methods.
Step 4 | Culture maintenance: The cell feeding schedule post-delivery should be adjusted according to the best conditions for the specific cell type. Careful handling of the cells during media changes is required to avoid cellular stress or detachment.
Step 5 | Assess gene delivery efficiency: Evaluate delivery efficiency using appropriate downstream readouts, such as fluorescence imaging, western blot, or flow cytometry.
To ensure experimental success, always follow the cell-specific protocol provided for each cell type product.
Maintaining cell attachment
Human iPSC-derived cells, particularly extended neuronal networks, are sensitive to mechanical stress. A common issue is cell peeling during media changes and transfection complex addition.
-
Gentle handling: The disruption of even a small area can cause a physical "tear" that impacts the entire culture. Avoid tilting the cell culture plate during media changes, as this creates fluid movement that can increase shear stress and cause peeling. Instead, we recommend removing the medium gently from the edge of the well and dispensing reagents slowly down the side wall to protect the cell monolayer.
-
Matrix preparation: Ensure the chosen specific matrix coating does not dry out before seeding. Allowing the matrix to dry will severely impact cellular adhesion and increase the likelihood of detachment during downstream mRNA transfection and lentiviral transduction workflows.
Balancing expression levels and cell viability
Weak expression or high cytotoxicity often relates to the dosing and quality of the cargo and reagents.
Weak expression, good viability:
-
When using an mRNA transfection protocol: This outcome generally indicates an underdose, a suboptimal mRNA-to-reagent ratio, or rapid mRNA degradation. To resolve this, increase the mRNA amount and adjust the mRNA:transfection reagent ratio accordingly. If the issue persists after mRNA amount and mRNA:reagent ratio optimisation, consider redesigning the mRNA for improved stability.
-
When using a lentiviral transduction protocol: This outcome usually points to a Multiplicity of Infection (MOI) that is too low.
Good expression, low viability:
-
mRNA transfection: This outcome is typically caused by an overdose of the transfection reagent or prolonged exposure to the transfection complex. To resolve this, reduce the amount of mRNA and reagent used, or reduce the exposure time of the transfection mix and adjust post-transfection feeding schedule to alleviate cellular stress.
-
Lentiviral transduction: Lentiviral transduction is generally gentler on sensitive cells, but applying an excessively high MOI can still cause significant cytotoxicity. Systematically titrate the MOI downwards to find the optimal balance between high transduction efficiency and preserving cell viability.
Weak expression, low viability:
-
mRNA transfection: This issue often results from reagent toxicity, a transgene that is inherently toxic, or poor-quality genetic material. Contamination with double-stranded RNA (dsRNA) or endotoxins can cause severe cytotoxicity during mRNA transfection. To resolve this, improve mRNA purity and ensure the construct is of the highest quality before beginning.
-
Lentiviral transduction: This can result from a transgene that is inherently toxic to the cells or impurities in the vector preparation. Lentivirus-containing supernatants must be precipitated using PEG-it鈩� Virus Precipitation Solution according to the manufacturer鈥檚 protocol. Keep in mind that the required amount of virus will depend on the culturing format, viral titer, and the desired MOI.
Mitigating well-to-well variability
High variability across the plate compromises data integrity and complicates functional readouts.
-
Consistent seeding: High well-to-well variability often stems from inconsistent seeding density or uneven cell distribution across the plate. To resolve this, ensure highly accurate cell counting prior to plating.
-
Transfection heterogeneity: This issue is typically caused by an uneven distribution of the reagents mix within or across the wells during gene delivery. To resolve this, ensure reagents are consistently premixed before adding them to the cells. Additionally, adding the complex during a media change can help distribute the reagents more evenly across the culture.
mRNA transfection of ioSensory Neurons
Download protocol
mRNA transfection of ioMotor Neurons
Download protocol
mRNA transfection of ioMicroglia
Download protocol
mRNA transfection of ioSkeletal Myocytes
Download protocol
mRNA transfection of ioGlutamatergic Neurons
Download protocol
Lentiviral transduction of ioGlutamatergic Neurons
Download protocol
Lentiviral transduction of ioMotor Neurons
Download protocol
Lentiviral transduction of ioGABAergic Neurons
Download protocol
Lentiviral transduction of ioMicroglia
Download protocol
Lentiviral transduction of ioSensory Neurons
Download protocol
Lentiviral transduction of ioSkeletal Myocytes
Download protocol